{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:36:27Z","timestamp":1791041787119,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.smrv.2008.05.002","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T08:40:17Z","timestamp":1222418417000},"page":"9-22","source":"Crossref","is-referenced-by-count":57,"title":["Hypocretin\/orexin disturbances in neurological disorders"],"prefix":"10.1016","volume":"13","author":[{"given":"Rolf","family":"Fronczek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Rainer","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert Jan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Lino","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Overeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2008.05.002_bib1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.smrv.2008.05.002_bib2","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2008.05.002_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2008.05.002_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2008.05.002_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.smrv.2008.05.002_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.smrv.2008.05.002_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.smrv.2008.05.002_bib8","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.smrv.2008.05.002_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0006-8993(99)01824-7","article-title":"Food intake elicited by central administration of orexins\/hypocretins: identification of hypothalamic sites of action","volume":"842","author":"Dube","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2008.05.002_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1006\/bbrc.1999.1998","article-title":"Inhibition of food intake by central injection of anti-orexin antibody in fasted rats","volume":"267","author":"Yamada","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.smrv.2008.05.002_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0006-8993(99)01905-8","article-title":"Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight","volume":"849","author":"Yamanaka","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2008.05.002_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0006-8993(99)01457-2","article-title":"Cardiovascular regulatory actions of the hypocretins in brain","volume":"831","author":"Samson","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2008.05.002_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0167-0115(00)00202-0","article-title":"Orexins: a role in medullary sympathetic outflow","volume":"96","author":"Dun","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.smrv.2008.05.002_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.smrv.2008.05.002_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1389-9457(02)00078-3","article-title":"Article reviewed: plasma orexin-A is\u00a0lower in patients with narcolepsy","volume":"3","author":"Nishino","year":"2002","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2008.05.002_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02476-4","article-title":"Plasma orexin-A is lower in patients with narcolepsy","volume":"318","author":"Higuchi","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2008.05.002_bib17","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1212\/WNL.56.12.1749","article-title":"Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients","volume":"56","author":"Dalal","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib18","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.smrv.2008.05.002_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(98)00977-X","article-title":"Orexin A-like immunoreactivity in the rat brain","volume":"260","author":"Chen","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2008.05.002_bib20","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0014-4886(03)00388-1","article-title":"Relationship between CSF hypocretin levels and hypocretin neuronal loss","volume":"184","author":"Gerashchenko","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.smrv.2008.05.002_bib22","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2008.05.002_bib23","doi-asserted-by":"crossref","unstructured":"Aziz NA, Fronczek R, Maat-Schieman MLC, Unmehopa UA, Roelandse FW, Overeem S, et\u00a0al. Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathology, 2008. doi:10.1111\/j.1750-3639.2008.00135.x.","DOI":"10.1111\/j.1750-3639.2008.00135.x"},{"key":"10.1016\/j.smrv.2008.05.002_bib24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","article-title":"Concomitant loss of dynorphin, NARP, and orexin in narcolepsy","volume":"65","author":"Crocker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","article-title":"Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy","volume":"65","author":"Blouin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2008.05.002_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-5728(01)00333-2","article-title":"Narcolepsy and the HLA region","volume":"117","author":"Lin","year":"2001","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.smrv.2008.05.002_bib28","series-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/j.smrv.2008.05.002_bib29","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/brain\/awl079","article-title":"Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults","volume":"129","author":"Mignot","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2008.05.002_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.74.1.127","article-title":"Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia","volume":"74","author":"Ebrahim","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.smrv.2008.05.002_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/WNL.59.4.639","article-title":"Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome","volume":"59","author":"Allen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib32","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1212\/01.WNL.0000094196.50155.38","article-title":"CSF hypocretin-1 levels in restless legs syndrome","volume":"61","author":"Stiasny-Kolster","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib33","article-title":"Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease","author":"Poceta","year":"2008","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2008.05.002_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1212\/WNL.55.2.281","article-title":"Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis","volume":"55","author":"Arnulf","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.287.4.455","article-title":"Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group","volume":"287","author":"Hobson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.smrv.2008.05.002_bib36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.58.3.498","article-title":"Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness","volume":"58","author":"Overeem","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-005-0614-5","article-title":"Parkinsonism with excessive daytime sleepiness\u00a0\u2013 a narcolepsy-like disorder?","volume":"252","author":"Baumann","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2008.05.002_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2006.08.004","article-title":"CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration","volume":"250","author":"Yasui","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.smrv.2008.05.002_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","article-title":"Low levels of ventricular CSF orexin\/hypocretin in advanced PD","volume":"61","author":"Drouot","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2008.05.002_bib41","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.72.6.798","article-title":"Sleep disorders and their determinants in multiple system atrophy","volume":"72","author":"Ghorayeb","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.smrv.2008.05.002_bib42","article-title":"CSF hypocretin-1 levels are normal in multiple-system atrophy","author":"Abdo","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.smrv.2008.05.002_bib43","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/mds.21668","article-title":"Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy","volume":"22","author":"Martinez-Rodriguez","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2008.05.002_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-006-0150-0","article-title":"Involvement of hypocretin neurons in multiple system atrophy","volume":"113","author":"Benarroch","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.smrv.2008.05.002_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000079749","article-title":"Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness","volume":"52","author":"Baumann","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.smrv.2008.05.002_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/REVNEURO.2007.18.3-4.223","article-title":"Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications","volume":"18","author":"Aziz","year":"2007","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.smrv.2008.05.002_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington's disease","volume":"14","author":"Petersen","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.smrv.2008.05.002_bib48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1399-0004.2006.00636.x","article-title":"Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease","volume":"70","author":"Bjorkqvist","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.smrv.2008.05.002_bib49","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1007\/s00415-006-0146-7","article-title":"Hypocretin-1 (orexin A) levels are normal in Huntington's disease","volume":"253","author":"Baumann","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2008.05.002_bib50","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/sleep\/28.12.1607","article-title":"CSF hypocretin levels are normal in Huntington's disease patients","volume":"28","author":"Gaus","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2008.05.002_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2005.09.028","article-title":"Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease","volume":"1063","author":"Meier","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.smrv.2008.05.002_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1081\/CBI-100101046","article-title":"Circadian rhythms and sleep in human aging","volume":"17","author":"Van Someren","year":"2000","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.smrv.2008.05.002_bib53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1212\/01.wnl.0000256731.57544.f9","article-title":"In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1","volume":"68","author":"Friedman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib54","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.sleep.2006.03.017","article-title":"Subjective and objective measures of insomnia in the context of traumatic brain injury: a preliminary study","volume":"7","author":"Ouellet","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2008.05.002_bib55","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/brain\/awm109","article-title":"Sleep\u2013wake disturbances 6 months after traumatic brain injury: a prospective study","volume":"130","author":"Baumann","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2008.05.002_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5664\/jcsm.26855","article-title":"Prevalence and consequences of sleep disorders in traumatic brain injury","volume":"3","author":"Castriotta","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.smrv.2008.05.002_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/brain\/94.1.165","article-title":"Hypothalamic lesions following closed head injury","volume":"94","author":"Crompton","year":"1971","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2008.05.002_bib58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(71)92680-8","article-title":"Brainstem lesions due to closed head injury","volume":"1","author":"Crompton","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.smrv.2008.05.002_bib59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/01.wnl.0000167605.02541.f2","article-title":"Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury","volume":"65","author":"Baumann","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib60","series-title":"Sleep disorders and neurologic disease","first-page":"117","article-title":"Secondary narcolepsy","author":"Scammell","year":"2007"},{"key":"10.1016\/j.smrv.2008.05.002_bib61","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1212\/WNL.33.12.1584","article-title":"Posttraumatic excessive daytime sleepiness: a review of 20 patients","volume":"33","author":"Guilleminault","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib62","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1212\/WNL.54.3.653","article-title":"Hypersomnia after head-neck trauma: a medicolegal dilemma","volume":"54","author":"Guilleminault","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib63","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00415-004-0442-z","article-title":"Low CSF hypocretin-1\/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis","volume":"251","author":"Oka","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.smrv.2008.05.002_bib64","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2169\/internalmedicine.42.743","article-title":"Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions","volume":"42","author":"Kato","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.smrv.2008.05.002_bib65","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/brain\/awh585","article-title":"Vivid dreams, hallucinations, psychosis and REM sleep in Guillain\u2013Barre syndrome","volume":"128","author":"Cochen","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2008.05.002_bib66","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/01.WNL.0000081049.14098.50","article-title":"CSF hypocretin levels in Guillain\u2013Barre syndrome and other inflammatory neuropathies","volume":"61","author":"Nishino","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(03)00085-5","article-title":"Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy","volume":"341","author":"Overeem","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.smrv.2008.05.002_bib68","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.smrv.2008.05.002_bib69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.WNL.0000101718.92619.67","article-title":"Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis","volume":"62","author":"Overeem","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib70","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","article-title":"REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis","volume":"30","author":"Compta","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2008.05.002_bib71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2869.2004.00385.x","article-title":"Sleep complaints in patients with myotonic dystrophy","volume":"13","author":"Laberge","year":"2004","journal-title":"J Sleep Res"},{"key":"10.1016\/j.smrv.2008.05.002_bib72","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/sleep\/25.6.662","article-title":"Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy","volume":"25","author":"Gibbs","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2008.05.002_bib73","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/sleep\/26.3.287","article-title":"Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness","volume":"26","author":"Martinez-Rodriguez","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2008.05.002_bib74","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/01.wnl.0000296827.20167.98","article-title":"The hypocretin neurotransmission system in myotonic dystrophy type 1","volume":"70","author":"Ciafaloni","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2008.05.002_bib75","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1460-9568.2006.05058.x","article-title":"REM sleep changes in rats induced by siRNA-mediated orexin knockdown","volume":"24","author":"Chen","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.smrv.2008.05.002_bib76","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.smrv.2008.05.002_bib77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.smrv.2007.07.010","article-title":"Narcolepsy: immunological aspects","volume":"12","author":"Overeem","year":"2008","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2008.05.002_bib78","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/29.5.601","article-title":"The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy","volume":"29","author":"Scammell","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2008.05.002_bib79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.02.010","article-title":"Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy","volume":"174","author":"Overeem","year":"2006","journal-title":"J Neuroimmunol"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079208000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079208000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T13:58:53Z","timestamp":1588946333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079208000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1087079208000543"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2008.05.002","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}